283 related articles for article (PubMed ID: 26489635)
41. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
42. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
[TBL] [Abstract][Full Text] [Related]
43. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
[TBL] [Abstract][Full Text] [Related]
44. Current trends in medical management of infantile hemangioma.
Ames JA; Sykes JM
Curr Opin Otolaryngol Head Neck Surg; 2015 Aug; 23(4):286-91. PubMed ID: 26101875
[TBL] [Abstract][Full Text] [Related]
45. Effects of oral propranolol on a juxtapapillary capillary hemangioma: a single-subject pilot study.
Tanabe H; Sahashi K; Kitano T; Tomita Y; Saito AM; Hirose H
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):380-3. PubMed ID: 25856826
[TBL] [Abstract][Full Text] [Related]
46. Serum apelin as a potential biomarker for infantile hemangiomas.
Chen Q; Zhang Y; Ni S; Yang L; Li J; Yuan X; Chen M; Liu J; Luo X; Xie Y; Wang H
Pediatr Blood Cancer; 2024 Jul; 71(7):e30989. PubMed ID: 38602300
[TBL] [Abstract][Full Text] [Related]
47. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
48. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
[TBL] [Abstract][Full Text] [Related]
49. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
Phillips RJ; Lokmic Z; Crock CM; Penington A
J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of superficial infantile hemangiomas with topical propranolol].
Niu JN; Xu GQ; Lü RR; Huo R
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
[TBL] [Abstract][Full Text] [Related]
52. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
Xue L; Sun C; Xu DP; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
[TBL] [Abstract][Full Text] [Related]
53. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
54. Propranolol for orbital hemangioma.
Taban M; Goldberg RA
Ophthalmology; 2010 Jan; 117(1):195-195.e4. PubMed ID: 20114117
[No Abstract] [Full Text] [Related]
55. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
56. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
57. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
[No Abstract] [Full Text] [Related]
58. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
59. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
60. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol.
Hadaschik E; Scheiba N; Engstner M; Flux K
J Cutan Pathol; 2012 Sep; 39(9):881-3. PubMed ID: 22764832
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
